Oshiro K, Koizumi M, Maruyama H, et al
A., Willoughby, D
Future Warnings Alison Cave, Chief Safety Officer of the MHRA, said: For the vast majority of patients who are prescribed GLP-1s, they are safe and effective medicines which deliver significant health benefits
Article 14 mins How Technology Will Transform Employee Benefits in the Next Five Years Advances in technology will not only transform healthcare and treatment outcomes benefit offerings, access to care, diagnosis, treatment and affordability challenges will also be radically changed
Diamond et al., Double-blind, Placebo-Controlled Evaluation of the Safety, Pharmacokinetic Properties and Pharmacodynamic effects of Intranasal PT-141 , a Melanocortin Receptor Agonist, in Healthy Males and Patients with Mild-to-Moderate Erectile Dysfunction